院外心脏骤停期间脑循环的院前监测——一项可行性研究
本研究在院外心脏骤停(OHCA)现场或转运途中使用INVOS™5100(n=13)和Root® O3(n=14)两种设备测量区域脑氧饱和度(rSO2),共27例纳入统计分析。INVOS™5100组达到ROSC者平均rSO2为54%(95%CI 40.3-67.7),未达到ROSC者为28%(95%CI 12.3-43.7),p=0.04;Root® O3组分别为50%(95%CI 46.5-53.5)和41%(95%CI 36.3-45.7),p=0.02。两组ETCO2值无统计学差异。急救人员对高级生命支持干扰程度的中位评分为2分(IQR 1-6,10分制)。作者认为两种设备均能在院前及转运中使用,且对高级生命支持干扰极小。
要点
- INVOS™5100组ROSC者平均rSO2 54%(95%CI 40.3-67.7) vs 未ROSC者28%(95%CI 12.3-43.7),p=0.04。
- Root® O3组ROSC者平均rSO2 50%(95%CI 46.5-53.5) vs 未ROSC者41%(95%CI 36.3-45.7),p=0.02。
- 两种设备组间ETCO2值无统计学差异。
- 急救人员对rSO2监测干扰高级生命支持的评分中位数为2分(IQR 1-6,10分制)。
- 作者认为两种设备均能在院前及转运中使用,且对高级生命支持干扰极小。
适用人群与场景
- 院外心脏骤停(OHCA)患者,由急救人员立即启动高级生命支持(ALS)。
处置流程与药物剂量
- 在OHCA现场或转运途中应用INVOS™5100或Root® O3传感器测量区域脑氧饱和度(rSO2),并手动记录rSO2值与呼气末二氧化碳(ETCO2)。
研究设计与关键结果
- 可行性研究,共27例OHCA患者纳入统计分析;INVOS™5100组13例,Root® O3组14例。
- INVOS™5100组:达到ROSC者平均rSO2 54%(95%CI 40.3-67.7),未达到ROSC者28%(95%CI 12.3-43.7),p=0.04。
- Root® O3组:达到ROSC者平均rSO2 50%(95%CI 46.5-53.5),未达到ROSC者41%(95%CI 36.3-45.7),p=0.02。
- 两组ETCO2值无统计学差异。
- 急救人员对监测干扰ALS的评分中位数为2(IQR 1-6),采用10分制数字评分量表。
证据类型、等级与局限
- 证据类型:可行性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,INVOS™5100和Root® O3均能在院前及转运中使用,且对高级生命支持干扰极小。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: About two-thirds of the in-hospital deaths after out-of-hospital cardiac arrests (OHCA) are a consequence of anoxic brain injuries, which are due to hypoperfusion of the brain during the cardiac arrests. Being able to monitor cerebral perfusion during cardiopulmonary resuscitation (CPR) is desirable to evaluate the effectiveness of the CPR and to guide further decision making and prognostication.
METHODS: Two different devices were used to measure regional cerebral oxygen saturation (rSO2): INVOS™ 5100 (Medtronic, Minneapolis, MN, USA) and Root® O3 (Masimo Corporation, Irvine, CA, USA). At the scene of the OHCA, advanced life support (ALS) was immediately initiated by the Emergency Medical Services (EMS) personnel. Sensors for measuring rSO2 were applied at the scene or during transportation to the hospital. rSO2 values were documented manually together with ETCO2 (end tidal carbon dioxide) on a worksheet specially designed for this study. The study worksheet also included a questionnaire for the EMS personnel with one statement on usability regarding potential interference with ALS.
RESULTS: Twenty-seven patients were included in the statistical analyses. In the INVOS™5100 group (n = 13), the mean rSO2 was 54% (95% CI 40.3-67.7) for patients achieving a return of spontaneous circulation (ROSC) and 28% (95% CI 12.3-43.7) for patients not achieving ROSC (p = 0.04). In the Root® O3 group (n = 14), the mean rSO2 was 50% (95% CI 46.5-53.5) and 41% (95% CI 36.3-45.7) (p = 0.02) for ROSC and no ROSC, respectively. ETCO2 values were not statistically different between the groups. The EMS personnel graded the statement of interference with ALS to a median of 2 (IQR 1-6) on a 10-point Numerical Rating Scale.
CONCLUSION: Our results suggest that both INVOS™5100 and ROOT® O3 can distinguish between ROSC and no ROSC in OHCA, and both could be used in the pre-hospital setting and during transport with minimal interference with ALS.
参考来源
- Henningsson A, Lannemyr L, Angerås O, et al. Prehospital monitoring of cerebral circulation during out of hospital cardiac arrest ? A feasibility study. Scand J Trauma Resusc Emerg Med. 2022. PMID: 36461052. doi:10.1186/s13049-022-01044-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。